EPIPEN
What it isEndogenous catecholamine with alpha and beta agonism; anaphylaxis, cardiac arrest and severe asthma.
Why this oneIt is the only drug that treats every element of anaphylaxis at once.
What limits itIn anaphylaxis it is intramuscular into the thigh, and delay is the main cause of death — there is no reason to wait.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypotension associated with septic shock | adult | IV infusion 0.05 mcg/kg/min | 0.05–2 mcg/kg/min, titrated to target MAP | 2 mcg/kg/min |
Titration May adjust every 10–15 min in increments of 0.05–0.2 mcg/kg/min to reach target MAP.
Renal Undefined
Hepatic Undefined
Pregnancy Decades of use identify no drug-associated risk of major birth defects/miscarriage; do not delay treatment for shock.
Lactation Low milk transfer expected (poor oral bioavailability, short half-life); do not delay treatment.
NO BOXED WARNINGS
Principal riskDelay is the main cause of death in anaphylaxis
Cost, est. cash$30–$500/month
Generic entry1984
Legacy pregnancy categoryC
Defining liabilityTremor, tachycardia or anticholinergic effects; excessive beta-agonist exposure can cause hypokalemia and arrhythmia.
